Company Profile
Updated: 17-SEP-09Pathway Investment Co.
Private Company, Headquarters Location
5099 S Division Ave., Cutlerville, MI 49548-5601, United States
(616)531-9191, (616)531-3267 fax,
Primary SIC: Security Brokers And Dealers, Primary NAICS: Securities Brokerage
Description: Finance: Stockbrokerage.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Philadelphia's Network for Teaching Entrepreneurship Celebrates Expansion, Honors Visionaries and Civic Leaders at Inaugural Gala.
Investment Weekly News; 12/5/2009; 936 words; ...Safeguard Scientifics and Co-Chair of the NFTE Philadelphia...the past two years as Co-Chair of the Philadelphia...young person will find a pathway to prosperity. Since...Financial, Investing, Investment, Marketing, Network...article was prepared by Investment Weekly News editors from...
Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution Network, Says Karkus.
PR Newswire; 12/3/2009; 1149 words; ...that further material investment in the Pharma subsidiary...opportunities, regulatory pathways, the need for further...warrant further reasonable investment in order to determine...CEO G.S. Schwartz & Co. (215) 345-0919...G.S. Schwartz & Co., +1-212-725...
Stone-built homes in historic setting.(Features)
The Journal (Newcastle, England); 11/28/2009; 801 words; ...the North East and are a great investment opportunity. "Quality homes...landscaped gardens and natural stone pathways. They will be fully decorated...countryandcoastalhomesgroup.co.uk INVESTMENT OPPORTUNITY An artist's impression...
Cannasat Therapeutics Announces New Chief Executive Officer: Anthony J. Giovinazzo, M.B.A., C.Dir.
Marketwire Canada; 11/16/2009; 1450 words; ...dedication over the last 5 years as co-founder and CEO, and look...experience ranges from the investment side as the former President...collaborations will create a pathway towards the future commercialization...well as provide important new investment to develop a pipeline of additional...
CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary.
Heart Disease Weekly; 11/15/2009; 1160 words; ...address the apoptotic pathway associated with a wide...President, CEO & Co-founder of CardioGene...President, CEO & Co-founder of Theragen...Commissiong, Ph.D., Co-founder of Amarantus...to raise a $1 million investment as a bridge to a $15...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning